Can Test Reports Be Reused for Overseas Registration of Laboratory Equipment?

Key Summary

A concise guide for medical device companies on reusing test reports for overseas registration of laboratory equipment, covering regulatory scope, risk classification, evidence requirements, common pitfalls, preparation checklists, and AIMEILI's professional interpretation.

Can Test Reports Be Reused for Overseas Registration of Laboratory Equipment?

Whether test reports can be reused for overseas registration of laboratory equipment depends on the target country's regulatory scope, product classification, and registration pathway. There is no one-size-fits-all answer. Companies should follow a systematic assessment: first confirm whether the product falls within the medical device regulatory scope in the target country, then determine the risk classification and corresponding registration pathway, and finally verify each existing test report against the applicable standards, issuing laboratory qualifications, and report validity period.

Published: 2026-08-24 22:31 | Updated: 2026-08-24 22:31

This article addresses priority questions that companies need to assess in actual projects involving international medical device registration, documentation preparation, compliance pathways, and post-market maintenance. It is compiled from AIMEILI's registration practice question bank, the medical device international registration knowledge base, and public regulatory information. For specific projects, the latest requirements of the target country's regulatory authority and the product documentation basis prevail.

Executive Summary

For products already registered with NMPA, CE marked, or FDA cleared/approved, performance verification data, electrical safety, and electromagnetic compatibility reports can be partially reused. However, labels and instructions for use, clinical evaluation, risk analysis, quality management system evidence, and local agent documentation often need to be re-prepared according to local regulations. Common risks include expired reports, unrecognized standards, laboratories not accepted locally, reports invalidated by product design changes, and neglecting post-market maintenance commitments.

Companies are advised to establish multi-country registration technical documentation in advance, using STED format and ISO 13485/MDSAP system evidence, and to secure certificate control through local authorized representatives. This maximizes test report reuse in GHWP member countries, Southeast Asia, the Middle East, Latin America, and other markets, reducing duplicate testing costs.

Applicable Scenarios and Core Questions

Laboratory equipment such as biochemical analyzers, hematology analyzers, and PCR thermal cyclers commonly raises the question: 'Can we reuse our test reports?' The underlying goal is to reduce duplicate testing expenses and shorten time to market.

The key to reuse is not whether the report shows a 'pass' result, but whether the target country accepts the standards, test methods, laboratory qualifications, and the timeliness of the report. Each country's regulatory system differs in product classification, registration pathways, and quality management system requirements.

Before deciding on reuse, companies must answer three questions: (1) Does the target country regulate this product as a medical device? (2) Which registration pathway corresponds to the product's risk classification? (3) Are the existing reports based on standards accepted by the target country or acceptable equivalent standards? Only when these conditions are met can the test reports serve as a basis for inclusion in the technical file.

Registration Decision Logic

Reuse decisions should follow a systematic logic, not just check the report cover. First, confirm whether the product falls within the target country's medical device regulatory scope. Laboratory equipment used solely for research rather than medical purposes may not fall under medical device regulations; equipment used for clinical sample testing to assist diagnosis typically is regulated as a medical device.

Second, determine the risk classification. Most laboratory equipment may fall under Class I, IIa, or IIb in the EU, Southeast Asia, the Middle East, etc., and Class II or III in China. Risk classification directly determines the registration pathway, the depth of technical documentation, and the type and quantity of test reports.

Third, evaluate reuse potential of existing reports. For NMPA-registered products, reports are usually based on Chinese standards; for CE-marked products, reports may be based on IEC 61010 series, ISO 15197, or IVDR-related standards; for FDA-cleared/approved products, reports may rely on FDA-recognized consensus standards. Whether the target country accepts these standards is the core of the decision.

Fourth, check local requirements for the report issuer. Some countries require that test reports be issued by a laboratory recognized by that country or listed in a specific accredited laboratory directory, which may prevent direct acceptance of existing reports.

Documentation and Evidence

When reusing test reports, companies need a complete technical documentation package, not just the reports themselves. Target country regulators typically require product description and intended use, risk management file, performance evaluation or clinical evidence, quality system certificate, and labels/instructions for use.

Test reports are only a part of the technical file. If the company can demonstrate that its quality management system complies with ISO 13485 or MDSAP and provide sufficient performance verification data, some original test reports may be accepted. Conversely, if the quality system does not cover target market requirements, retesting may be required even if the report is valid.

For GHWP member countries or multi-country registration projects, companies can build a core technical file (STED format) and localize it as needed. Test reports can often be reused, but supplementary specific tests, such as electrical safety, EMC, and biocompatibility, may be required based on local registration requirements.

In addition, pay attention to the version and validity of reports. Many countries require reports issued within a specific period, e.g., three or five years. Expired reports cannot be used directly as evidence for a current application and may need to be updated.

Common Mistakes

Assuming that a test report is a universal certificate, without verifying the standards and laboratory qualifications accepted by the target country.
Ignoring that product use and classification may differ across countries, leading to incorrect regulatory and pathway determination.
Using test reports as the only evidence in the technical file, lacking risk management, performance evaluation, and QMS support.
Overlooking report validity and impact of product design changes; reports not corresponding to the current product version.
Not confirming the role of a local agent or authorized representative in advance, leading to incomplete submissions or communication delays.

Company Preparation Checklist

Establish a target country regulation and standards comparison table, clarifying acceptance requirements for each test.
Compile a list of existing test reports, including report number, test item, standard basis, issuing organization, and validity period.
Verify the scope of the quality management system; add MDSAP certification if necessary to share system evidence across multiple countries.
Prepare STED-format core technical documentation, describing the relationship between test reports and risk management, clinical evidence, labels, and instructions.
Confirm document format and language requirements with the local agent or authorized representative, allowing time for translation and notarization.
Develop a post-market surveillance plan, including change reporting and adverse event reporting mechanisms, described in the registration application.

AIMEILI Perspective

As a regulatory consulting firm, AIMEILI believes that companies often mistake 'can we reuse' as a simple yes/no question, while neglecting 'how to reuse' and 'how to prove reuse.'

Companies should assess reuse feasibility before project initiation, not when reports are about to expire. Ideally, when completing domestic registration or CE certification, design testing plans with multi-country registration needs in mind, use internationally accepted standards where possible, and retain complete raw test data.

Reusable documents include basic performance data, electrical safety and EMC reports, and risk management reports. Documentation that requires localization includes labels/instructions, registration application forms, and clinical evaluation sections addressing ethnic differences or local epidemiology.

Local agents and certificate control are critical. Overseas registration certificates are often held only by a local certificate holder. The company must sign a clear agreement with the agent defining certificate ownership, change notification obligations, and renewal responsibilities. Otherwise, the certificate may become uncontrollable if the partnership changes.

For multi-country registration, build a unified core technical file and list country-specific differences separately. This avoids duplicate work and reduces the risk of correction due to document version confusion.

Frequently Asked Follow-ups

If a test report is exactly identical, can it be submitted directly? Even if the report's signatures, data, and standards are identical, it cannot be submitted directly. Different countries require different application forms, language versions, and document formats, and typically require a letter of authorization from the local agent. Therefore, the test report can only serve as one piece of evidence and cannot be the entire technical file.

How is the validity of an existing report calculated? Validity is generally calculated from the report issue date, not the test start date. The target country may require that the report be valid at the time of application submission, and some countries require the report to remain valid throughout the registration certificate's validity period. If a major design change occurs, the report must be re-assessed.

Are CE or FDA test reports accepted by other countries? Some GHWP member countries accept test reports issued by accredited laboratories based on international standards, but usually with additional conditions, such as providing the laboratory accreditation certificate, raw data, and risk assessment. They may not directly accept the CE or FDA designation itself, but rather evaluate whether the test itself meets the requirements.

Content Review and Applicability Boundaries

Content Author: AIMEILI Regulatory Editorial Board

Professional Review: AIMEILI Medical Device International Registration Project Team

Source Principle: Priority is given to official regulatory authorities, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as supplementary references.

Applicability Boundary: This article is intended for preliminary understanding, documentation preparation, and project planning, and does not replace formal requirements from target country regulatory authorities, test conclusions, or legal opinions.

Source and Language Notice

View Chinese original page

Need a registration pathway assessment?

Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.

Contact AIMEILI

Can Test Reports Be Reused for Overseas Registration of Laboratory Equipment?